BridgeBio Oncology Therapeutics Inc.
USD8.72
+0.30 (+3.56%)
CEO
Pedro J. Beltran
IPO Date
2025-08-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.40
Prev. Close
$8.42
Day Low
$8.33
Day High
$9.15
52W Low
$7.00
52W High
$14.87
Market Cap
$0.70B
Volume
0.43M
| 343 |
| $7.80 |
| 6 Jul 2026 | Ben Yong | Chief Med & Dev Officer | F-InKind | Disposed | 1,047 | $7.80 |
| 6 Jul 2026 | Beltran Pedro | director, officer: President and CEO | F-InKind | Disposed | 1,047 | $7.80 |
| 6 Jul 2026 | Chen Bihua | director, 10 percent owner: | J-Other | Disposed | 4,528,186 | $0.00 |
| 6 Jul 2026 | Chen Bihua | director, 10 percent owner: | J-Other | Acquired | 2,692,459 | $0.00 |
| 6 Jul 2026 | Chen Bihua | director, 10 percent owner: | J-Other | Acquired | 1,704,862 | $0.00 |
| 6 Jul 2026 | Chen Bihua | director, 10 percent owner: | J-Other | Acquired | 130,865 | $0.00 |
| 18 Jun 2026 | Tipirneni Praveen P. | director | A-Award | Acquired | 31,675 | $7.73 |
| 18 Jun 2026 | MCCORMICK FRANK | director | A-Award | Acquired | 31,675 | $7.73 |